Putative uncharacterized protein FLJ40288 (FLJ40288)

FLJ40288 refers to a putative, uncharacterized protein identified by prediction and cDNA sequencing in the human genome. Its sequence and chromosomal locus (frequently referenced on 7q32.3) are known, but there are no validated data identifying it as a functional receptor, enzyme, transporter, transcription factor, or other therapeutically actionable biomolecule. It is listed in various genomic analyses as being differentially expressed or altered at the DNA or RNA level in certain cancer studies, such as cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC), but no direct biological function, pathway involvement, disease mechanism, or drug interaction has been described[1][3]. The name 'FLJ40288' is an early accession (e.g., from FLJ cDNA prediction projects), not a formal designation as a receptor or target. The entry has been used as a locus tag or uncharacterized gene symbol in databases but remains uncharacterized and with unknown function. There is no evidence that FLJ40288 refers to a druggable receptor, enzyme, or other target class molecule. The presence of alternative names (KB-1183D5.11, RP11-357H14.2) reflects cDNA clone nomenclature, not functional characterization. Its citation in cancer studies results only from genomic surveys correlating chromosomal aberrations or expression changes, not from functional or mechanistic studies[1][3]. Given this, FLJ40288 is a putative/unspecified gene product with no established target class, function, disease role, or therapeutic relevance at this time.

Other names

FLJ40288KB-1183D5.11RP11-357H14.2